ADVANZ Pharma Canada Inc.
Registration:
2
of
2
(2023-10-19
to
2024-02-14)
Details Regarding the Identified Subject Matter
|
Specific Topics of Lobbying Communications
|
Intended Outcomes
|
Associated Subject Matters
|
Introduce ADVANZ as a new entrant in Canada's biopharmaceutical sector to key government officials, and to raise awareness of progressive non-viral liver diseases. They also look to discuss policies and programs related to drug approvals, drug listings and reimbursement in B.C.
|
Decision by the Executive Council or a member of the Executive Council to have the private sector instead of the Crown provide goods or services to the government of British Columbia or a Provincial entity, Development, establishment, amendment or termination of any program, policy, directive or guideline of the government of British Columbia or a Provincial entity, Awarding, amendment or termination of any contract, grant or financial benefit by or on behalf of the government of British Columbia or a Provincial entity
|
Economic Development and Trade, Health, Hospitals, Science and Technology
|